Watson David O. - 13 Jan 2026 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
General Counsel
Signature
David Watson
Issuer symbol
APLS
Transactions as of
13 Jan 2026
Net transactions value
-$128,242
Form type
4
Filing time
15 Jan 2026, 16:28:18 UTC
Previous filing
09 Jan 2026
Next filing
21 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Watson David O. General Counsel C/O APELLIS PHARMACEUTICALS, INC, 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM David Watson 14 Jan 2026 0001657719

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $128,242 -5,780 -5.5% $22.19 98,838 13 Jan 2026 Direct F1
holding APLS Common Stock 10,000 13 Jan 2026 Indirect Owner (Custodial Account for minor children) F2
holding APLS Common Stock 50,136 13 Jan 2026 Indirect Owner (The David O. Watson Irrevocable Trust of 2023) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 12, 2026.
F2 This represents a custodial account held by the reporting person for the sole benefit of his minor children.
F3 The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.